Choosing depression treatment in type 2 diabetes: integrating psychiatric efficacy, metabolic effects, and cardiovascular risk. A narrative review
Depression in people with type 2 diabetes (T2D) complicates daily self-management and treatment selection. Psychiatric benefit must be considered alongside weight, glycaemia, cardiovascular tolerability and interactions. This narrative review draws on purposively selected literature and distinguishes direct T2D evidence from mixed-diabetes studies, observational associations and indirect…
Read original article on Frontiers in Psychiatry | New and Recent Articles →Related news
-
Essays in Idleness
United States
-
SDS screen-positive prediction from structured questionnaires in university students: a comparative evaluation of large language model prompting strategies
Switzerland
-
Experiences of exercise and mental well-being among psychiatric inpatients: a qualitative study
Switzerland
-
Exercise physiology and speech pathology support treatment engagement in forensic mental health in community health: evidence from a retrospective cohort study
Switzerland
-
The reliability of the adverse childhood experiences questionnaire for late postpartum use in relation to maternal emotional health
Switzerland
-
Air mass advection and immune dysregulation in schizophrenia: an exploratory pilot study
Switzerland
-
“As long as you can make it to work the next day”: normalized drinking and problem recognition among individuals in recovery from alcohol use disorder
Switzerland
-
Perceived artificial intelligence dependence and anxiety symptoms among university students: a three-wave study of experiential avoidance and digital literacy
Switzerland